Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ueda

Showing results (311-320 of 333) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2007
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801Kunihiro Tsukasaki, Atae Utsunomiya, Haruhiko Fukuda, et al.
FEBS Open Bio|December 8, 2018
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining regionShohei Mizuno, Ichiro Hanamura, Akinobu Ota, et al.
British Journal of Haematology|March 4, 2015
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II studyTakashi Ishida, Tatsuro Jo, Shigeki Takemoto, et al.
Blood Advances|October 22, 2020
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational studyKentaro Yonekura, Shigeru Kusumoto, Ilseung Choi, et al.
Blood|July 5, 2005
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemiaTatsuya Suzuki, Hitoshi Kiyoi, Kazutaka Ozeki, et al.
Annals of Hematology|July 29, 2018
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphomaDai Maruyama, Kunihiro Tsukasaki, Toshiki Uchida, et al.
Annals of Hematology|July 6, 2018
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphomaDai Maruyama, Kunihiro Tsukasaki, Toshiki Uchida, et al.
Haematologica|April 14, 2022
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphomaNorio Tanaka, Seiichi Mori, Kazuma Kiyotani, et al.
Cell Death Discovery|May 26, 2021
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemiaSivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, et al.
Leukemia Research|November 12, 2013
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myelomaAtsushi Inagaki, Emi Tajima, Miyuki Uranishi, et al.
Pageof 34

Showing results (311-320 of 333) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2007
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801Kunihiro Tsukasaki, Atae Utsunomiya, Haruhiko Fukuda, et al.
FEBS Open Bio|December 8, 2018
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining regionShohei Mizuno, Ichiro Hanamura, Akinobu Ota, et al.
British Journal of Haematology|March 4, 2015
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II studyTakashi Ishida, Tatsuro Jo, Shigeki Takemoto, et al.
Blood Advances|October 22, 2020
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational studyKentaro Yonekura, Shigeru Kusumoto, Ilseung Choi, et al.
Blood|July 5, 2005
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemiaTatsuya Suzuki, Hitoshi Kiyoi, Kazutaka Ozeki, et al.
Annals of Hematology|July 29, 2018
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphomaDai Maruyama, Kunihiro Tsukasaki, Toshiki Uchida, et al.
Annals of Hematology|July 6, 2018
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphomaDai Maruyama, Kunihiro Tsukasaki, Toshiki Uchida, et al.
Haematologica|April 14, 2022
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphomaNorio Tanaka, Seiichi Mori, Kazuma Kiyotani, et al.
Cell Death Discovery|May 26, 2021
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemiaSivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, et al.
Leukemia Research|November 12, 2013
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myelomaAtsushi Inagaki, Emi Tajima, Miyuki Uranishi, et al.
Pageof 34